Insider trades
David Happel, CEO of Sagimet Biosciences SGMT, has filed 3 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $64.9K. The latest trade was on 05/28.
David Happel
President & CEO
- Company
- Sagimet Biosciences SGMT
- First filing
- 23/07/20
- Trades
- 13 trades
- Buys / sales
- 3 / 2
- 12-month net buying
- −$64.9K
- Last trade
- 05/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 02/10 | 02/12 | 12,101 sh | $5.36 | $64,861.36 | −1.8% | |
| Open-market sale | 25/07/21 | 25/07/23 | 65,478 sh | $9.13 | $597,814.14 | −8.7% | |
| Open-market buy | 24/03/26 | 24/03/28 | 12,100 sh | $5.27 | $63,767 | +1.9% | |
| Open-market buy | 23/12/07 | 23/12/08 | 1,600 sh | $4.10 | $6,560 | +0.3% | |
| Open-market buy | 23/11/16 | 23/11/20 | 590 sh | $2.35 | $1,386.5 | No record |